GRAIL
Leslie Ann Cruz PhD, RAC, LHEP™ is an accomplished professional in regulatory affairs with extensive experience across various roles in the biotechnology and pharmaceutical sectors. Currently serving as Associate Director of Regulatory Affairs at GRAIL since June 2022, Leslie's previous positions include Director and Associate Director of Regulatory Affairs at Natera and Regulatory Affairs Associate at Optovue, where strong contributions included managing international regulatory registrations and completing numerous 510K submissions for medical devices. Leslie's expertise is further backed by a solid academic foundation, including a PhD in Chemistry and Chemical Biology from the University of California, San Francisco, and a BS in Chemistry from the University of Chicago. Throughout a diverse career, Leslie has demonstrated proficiency in technical writing, project management, and compliance with regulatory guidelines, contributing significantly to the advancement of drug and device combination products.
This person is not in any teams
GRAIL
28 followers
GRAIL aims to develop a blood test to detect cancer early before symptoms appear offering higher survival rates compared to late-stage diagnosis.